Search Results - "Gagnieu, Marie Claude"
-
1
-
2
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice
Published in Fundamental & clinical pharmacology (01-06-2015)“…Irinotecan is a major drug in the treatment of advanced colorectal cancer. Its active form is the SN38 metabolite, which is cleared by the biliary route after…”
Get full text
Journal Article -
3
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells
Published in Scientific reports (17-03-2021)“…Accumulation in target cells is an essential pharmacokinetic step of targeted therapies. Tyrosine Kinase Inhibitors (TKI) against the BCR-ABL fusion protein in…”
Get full text
Journal Article -
4
Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin
Published in Pharmaceutics (04-01-2022)“…Daptomycin is a candidate for therapeutic drug monitoring (TDM). The objectives of this work were to implement and compare two pharmacometric tools for…”
Get full text
Journal Article -
5
Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients
Published in PloS one (24-11-2021)“…Therapeutic drug monitoring (TDM) is essential for voriconazole to ensure optimal drug exposure, mainly in critically ill patients for whom voriconazole…”
Get full text
Journal Article -
6
Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections
Published in Antimicrobial agents and chemotherapy (01-05-2016)“…The interindividual and intraindividual variabilities in daptomycin pharmacokinetics were investigated in 23 patients (69 pharmacokinetic profiles) who were…”
Get full text
Journal Article -
7
Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection
Published in Frontiers in medicine (31-03-2021)“…Suppressive parenteral antibiotic therapy with beta-lactams may be necessary in patients with Gram-negative bone and joint infection (BJI). Subcutaneous drug…”
Get full text
Journal Article -
8
-
9
Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center
Published in BMC infectious diseases (17-02-2016)“…Even if daptomycin does not have approval for the treatment of bone and joint infections (BJI), the Infectious Diseases Society of America guidelines propose…”
Get full text
Journal Article -
10
Genotypic screening of the main opiate-related polymorphisms in a cohort of 139 sickle cell disease patients
Published in American journal of hematology (01-05-2012)“…Because no frequency data are available for the main opiate-related polymorphisms in sickle-cell disease (SCD) populations, we decided to perform such a…”
Get full text
Journal Article -
11
Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study
Published in PloS one (07-01-2013)“…The use of the immunosuppressant sirolimus in kidney transplantation has been made problematic by the frequent occurrence of various side effects, including…”
Get full text
Journal Article -
12
The Roche Total Mycophenolic Acid® assay: An application protocol for the ABX Pentra 400 analyzer and comparison with LC–MS in children with idiopathic nephrotic syndrome
Published in Practical laboratory medicine (01-04-2017)“…For TDM of mycophenolate acid (MPA), the Roche Total Mycophenolic Acid® assay based on the inhibition of recombinant inosine monophosphate dehydrogenase…”
Get full text
Journal Article -
13
Pharmacokinetic-Pharmacodynamic Modeling of Unboosted Atazanavir in a Cohort of Stable HIV-Infected Patients
Published in Antimicrobial Agents and Chemotherapy (01-01-2013)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
14
Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients
Published in Antiviral therapy (01-01-2008)“…Pegylated interferon/ribavirin combination is currently the standard treatment for chronic hepatitis C virus (HCV) infection. Body weight adjustment of…”
Get full text
Journal Article -
15
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
Published in Antiviral research (01-09-2020)“…In the context of the COVID-19 pandemic, several drugs have been repurposed as potential candidates for the treatment of COVID-19 infection. While preliminary…”
Get full text
Journal Article -
16
Population Pharmacokinetics of Tenofovir in AIDS Patients
Published in Journal of clinical pharmacology (01-11-2008)“…The interindividual variability of tenofovir pharmacokinetics in HIV+ patients is quite large, but the sources of variability are incompletely understood…”
Get full text
Journal Article -
17
Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients
Published in Clinical transplantation (01-07-2011)“…Vallin M, Guillaud O, Morard I, Gagnieu M‐C, Mentha G, Adham M, Morelon E, Boillot O, Giostra E, Dumortier J. Tolerability of everolimus‐based…”
Get full text
Journal Article -
18
Everolimus for refractory Crohn's disease: A case report
Published in Inflammatory bowel diseases (01-06-2008)Get full text
Journal Article -
19
Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (01-07-2007)“…A sensitive high-performance liquid chromatography method coupled to UV and single mass spectrometry (MS) detection was developed for the determination of…”
Get full text
Journal Article -
20
Conversion from mycophenolate mofetil to enteric‐coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study
Published in Liver transplantation (01-09-2006)“…Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of this prospective study was to…”
Get full text
Journal Article